The office building, which once housed pharmaceutical giant Pfizer, was evacuated Tuesday morning after construction workers noticed cracks and buckling columns.
Innovent Biologics rose as much as 10%, after entering a strategic global licensing and collaboration agreement with Pfizer to develop oncology medicines.
The data on Pfizer's GLP-1 offer early evidence that the injection can be administered less frequently than existing drugs without sacrificing efficacy.